clinical 1,384 words KG: AD 2026-03-24
kind:clinical-trialsection:clinical-trialsstate:published
Contents

Bilingualism Cognitive Reserve AD Trial

Knowledge Graph

Related Hypotheses (30)

Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuro
Score: 0.42
Multi-Modal Stress Response Harmonization
Score: 0.60
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
SASP-Driven Aquaporin-4 Dysregulation
Score: 0.59
PARP1 Inhibition Therapy
Score: 0.58

Related Analyses (4)

Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed

Related Experiments (9)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.40
AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.40
Sex Differences in Alzheimer's Disease — mechanisms and ther
clinical · proposed · Score: 0.40
cGAS-STING Pathway Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40

See Also (14)

Tau Consortium
organization · KG edge: associated_with
Proteome Atlas for Neurodegenerative Diseases
mechanism · KG edge: regulates
Age-Sensitive Cortical Vulnerability in Parkinson's Dis
mechanism · KG edge: associated_with
Packard Center for ALS Research
institution · KG edge: implicated_in
Dementia Australia
institution · KG edge: causes

Knowledge Graph (12 edges)

AD causes neurodegeneration
AD inhibits cholinergic_transmission
AD causes memory_loss
AD associated_with TAU
AD regulates PROTEOME
AD associated_with GLYCOLYTIC_PATHWAY
AD causes IMMUNE_TOL
AD causes DEMENTIA
AD associated_with CHOLINERGIC_TRANSMISSION
TAU associated_with AD